nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—UGT1A9—Irinotecan Pathway—NPC1—atherosclerosis	0.0295	0.157	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—PLTP—atherosclerosis	0.0109	0.0578	CbGpPWpGaD
Entacapone—COMT—Dopamine metabolism—SOD1—atherosclerosis	0.00907	0.048	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—CYP7A1—atherosclerosis	0.00678	0.0359	CbGpPWpGaD
Entacapone—COMT—Estrogen metabolism—GSTM1—atherosclerosis	0.00627	0.0332	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—APOA2—atherosclerosis	0.00594	0.0315	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—APOA5—atherosclerosis	0.00543	0.0288	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—APOC3—atherosclerosis	0.00447	0.0237	CbGpPWpGaD
Entacapone—UGT1A9—Estrogen metabolism—GSTM1—atherosclerosis	0.00375	0.0199	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—AHR—atherosclerosis	0.00328	0.0174	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP7A1—atherosclerosis	0.0025	0.0132	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00246	0.013	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—PPARA—atherosclerosis	0.00243	0.0129	CbGpPWpGaD
Entacapone—COMT—Biological oxidations—CYP27A1—atherosclerosis	0.00231	0.0122	CbGpPWpGaD
Entacapone—UGT1A9—PPAR Alpha Pathway—APOA1—atherosclerosis	0.00228	0.0121	CbGpPWpGaD
Entacapone—COMT—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00227	0.0121	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CYP7A1—atherosclerosis	0.00214	0.0113	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP7A1—atherosclerosis	0.00209	0.0111	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—APOA2—atherosclerosis	0.00187	0.00993	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA2—atherosclerosis	0.00183	0.00971	CbGpPWpGaD
Entacapone—COMT—Phase II conjugation—GSTM1—atherosclerosis	0.00176	0.00933	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—APOA5—atherosclerosis	0.00171	0.00908	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA5—atherosclerosis	0.00168	0.00888	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP7A1—atherosclerosis	0.00149	0.00792	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP7A1—atherosclerosis	0.00147	0.00781	CbGpPWpGaD
Entacapone—Pharyngitis—Pravastatin—atherosclerosis	0.00145	0.00179	CcSEcCtD
Entacapone—Muscle spasms—Lovastatin—atherosclerosis	0.00145	0.00179	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP7A1—atherosclerosis	0.00144	0.00764	CbGpPWpGaD
Entacapone—Visual impairment—Niacin—atherosclerosis	0.00143	0.00177	CcSEcCtD
Entacapone—Alopecia—Simvastatin—atherosclerosis	0.00143	0.00176	CcSEcCtD
Entacapone—Back pain—Ezetimibe—atherosclerosis	0.00143	0.00176	CcSEcCtD
Entacapone—Nervous system disorder—Rosuvastatin—atherosclerosis	0.00142	0.00175	CcSEcCtD
Entacapone—Muscle spasms—Ezetimibe—atherosclerosis	0.00142	0.00175	CcSEcCtD
Entacapone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00142	0.00175	CcSEcCtD
Entacapone—Vision blurred—Lovastatin—atherosclerosis	0.00142	0.00175	CcSEcCtD
Entacapone—Mental disorder—Simvastatin—atherosclerosis	0.00142	0.00175	CcSEcCtD
Entacapone—Tremor—Lovastatin—atherosclerosis	0.00141	0.00174	CcSEcCtD
Entacapone—Visual impairment—Pravastatin—atherosclerosis	0.00141	0.00174	CcSEcCtD
Entacapone—Ill-defined disorder—Lovastatin—atherosclerosis	0.0014	0.00172	CcSEcCtD
Entacapone—Eye disorder—Niacin—atherosclerosis	0.00139	0.00171	CcSEcCtD
Entacapone—Flatulence—Simvastatin—atherosclerosis	0.00139	0.00171	CcSEcCtD
Entacapone—Erythema multiforme—Pravastatin—atherosclerosis	0.00138	0.00171	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—CYP27A1—atherosclerosis	0.00138	0.00732	CbGpPWpGaD
Entacapone—Dysgeusia—Simvastatin—atherosclerosis	0.00138	0.0017	CcSEcCtD
Entacapone—Flushing—Niacin—atherosclerosis	0.00138	0.0017	CcSEcCtD
Entacapone—Angioedema—Lovastatin—atherosclerosis	0.00138	0.0017	CcSEcCtD
Entacapone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00137	0.00169	CcSEcCtD
Entacapone—UGT1A9—Metapathway biotransformation—CYP27A1—atherosclerosis	0.00136	0.00722	CbGpPWpGaD
Entacapone—Malaise—Lovastatin—atherosclerosis	0.00136	0.00167	CcSEcCtD
Entacapone—Flushing—Pravastatin—atherosclerosis	0.00136	0.00167	CcSEcCtD
Entacapone—Cardiac disorder—Pravastatin—atherosclerosis	0.00136	0.00167	CcSEcCtD
Entacapone—Muscle spasms—Simvastatin—atherosclerosis	0.00136	0.00167	CcSEcCtD
Entacapone—Vertigo—Lovastatin—atherosclerosis	0.00135	0.00167	CcSEcCtD
Entacapone—Angioedema—Ezetimibe—atherosclerosis	0.00135	0.00166	CcSEcCtD
Entacapone—Leukopenia—Lovastatin—atherosclerosis	0.00135	0.00166	CcSEcCtD
Entacapone—Malaise—Ezetimibe—atherosclerosis	0.00133	0.00164	CcSEcCtD
Entacapone—Vision blurred—Simvastatin—atherosclerosis	0.00133	0.00164	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00132	0.00163	CcSEcCtD
Entacapone—Tremor—Simvastatin—atherosclerosis	0.00132	0.00163	CcSEcCtD
Entacapone—Alopecia—Niacin—atherosclerosis	0.00131	0.00162	CcSEcCtD
Entacapone—Insomnia—Rosuvastatin—atherosclerosis	0.00131	0.00162	CcSEcCtD
Entacapone—Ill-defined disorder—Simvastatin—atherosclerosis	0.00131	0.00161	CcSEcCtD
Entacapone—Palpitations—Ezetimibe—atherosclerosis	0.00131	0.00161	CcSEcCtD
Entacapone—Paraesthesia—Rosuvastatin—atherosclerosis	0.0013	0.00161	CcSEcCtD
Entacapone—Malnutrition—Niacin—atherosclerosis	0.00129	0.0016	CcSEcCtD
Entacapone—Alopecia—Pravastatin—atherosclerosis	0.00129	0.00159	CcSEcCtD
Entacapone—Cough—Ezetimibe—atherosclerosis	0.00129	0.00159	CcSEcCtD
Entacapone—Angioedema—Simvastatin—atherosclerosis	0.00129	0.00159	CcSEcCtD
Entacapone—Myalgia—Lovastatin—atherosclerosis	0.00128	0.00158	CcSEcCtD
Entacapone—Chest pain—Lovastatin—atherosclerosis	0.00128	0.00158	CcSEcCtD
Entacapone—Anxiety—Lovastatin—atherosclerosis	0.00128	0.00158	CcSEcCtD
Entacapone—Dyspepsia—Rosuvastatin—atherosclerosis	0.00128	0.00157	CcSEcCtD
Entacapone—Hypertension—Ezetimibe—atherosclerosis	0.00128	0.00157	CcSEcCtD
Entacapone—Flatulence—Niacin—atherosclerosis	0.00128	0.00157	CcSEcCtD
Entacapone—Malaise—Simvastatin—atherosclerosis	0.00127	0.00157	CcSEcCtD
Entacapone—Tension—Niacin—atherosclerosis	0.00127	0.00157	CcSEcCtD
Entacapone—Discomfort—Lovastatin—atherosclerosis	0.00127	0.00156	CcSEcCtD
Entacapone—Vertigo—Simvastatin—atherosclerosis	0.00127	0.00156	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—APOA2—atherosclerosis	0.00126	0.00669	CbGpPWpGaD
Entacapone—Leukopenia—Simvastatin—atherosclerosis	0.00126	0.00156	CcSEcCtD
Entacapone—Myalgia—Ezetimibe—atherosclerosis	0.00126	0.00155	CcSEcCtD
Entacapone—Chest pain—Ezetimibe—atherosclerosis	0.00126	0.00155	CcSEcCtD
Entacapone—Nervousness—Niacin—atherosclerosis	0.00126	0.00155	CcSEcCtD
Entacapone—Flatulence—Pravastatin—atherosclerosis	0.00126	0.00155	CcSEcCtD
Entacapone—Dry mouth—Lovastatin—atherosclerosis	0.00125	0.00155	CcSEcCtD
Entacapone—Tension—Pravastatin—atherosclerosis	0.00125	0.00154	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.00125	0.00154	CcSEcCtD
Entacapone—Dysgeusia—Pravastatin—atherosclerosis	0.00125	0.00154	CcSEcCtD
Entacapone—Muscle spasms—Niacin—atherosclerosis	0.00124	0.00153	CcSEcCtD
Entacapone—Discomfort—Ezetimibe—atherosclerosis	0.00124	0.00153	CcSEcCtD
Entacapone—Constipation—Rosuvastatin—atherosclerosis	0.00124	0.00153	CcSEcCtD
Entacapone—Pain—Rosuvastatin—atherosclerosis	0.00124	0.00153	CcSEcCtD
Entacapone—Confusional state—Lovastatin—atherosclerosis	0.00124	0.00153	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—HMGCR—atherosclerosis	0.00124	0.00656	CbGpPWpGaD
Entacapone—Nervousness—Pravastatin—atherosclerosis	0.00124	0.00153	CcSEcCtD
Entacapone—Dry mouth—Ezetimibe—atherosclerosis	0.00123	0.00152	CcSEcCtD
Entacapone—Muscle spasms—Pravastatin—atherosclerosis	0.00123	0.00151	CcSEcCtD
Entacapone—Vision blurred—Niacin—atherosclerosis	0.00122	0.0015	CcSEcCtD
Entacapone—Confusional state—Ezetimibe—atherosclerosis	0.00122	0.0015	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—HMGCR—atherosclerosis	0.00121	0.00642	CbGpPWpGaD
Entacapone—Thrombocytopenia—Lovastatin—atherosclerosis	0.0012	0.00148	CcSEcCtD
Entacapone—Vision blurred—Pravastatin—atherosclerosis	0.0012	0.00148	CcSEcCtD
Entacapone—Myalgia—Simvastatin—atherosclerosis	0.0012	0.00148	CcSEcCtD
Entacapone—Chest pain—Simvastatin—atherosclerosis	0.0012	0.00148	CcSEcCtD
Entacapone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.0012	0.00147	CcSEcCtD
Entacapone—Anxiety—Simvastatin—atherosclerosis	0.0012	0.00147	CcSEcCtD
Entacapone—Tremor—Pravastatin—atherosclerosis	0.00119	0.00147	CcSEcCtD
Entacapone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00119	0.00146	CcSEcCtD
Entacapone—Discomfort—Simvastatin—atherosclerosis	0.00119	0.00146	CcSEcCtD
Entacapone—Nervous system disorder—Ezetimibe—atherosclerosis	0.00118	0.00146	CcSEcCtD
Entacapone—Angioedema—Niacin—atherosclerosis	0.00118	0.00146	CcSEcCtD
Entacapone—Ill-defined disorder—Pravastatin—atherosclerosis	0.00118	0.00146	CcSEcCtD
Entacapone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00118	0.00146	CcSEcCtD
Entacapone—Anorexia—Lovastatin—atherosclerosis	0.00117	0.00144	CcSEcCtD
Entacapone—Skin disorder—Ezetimibe—atherosclerosis	0.00117	0.00144	CcSEcCtD
Entacapone—Angioedema—Pravastatin—atherosclerosis	0.00116	0.00144	CcSEcCtD
Entacapone—Vertigo—Niacin—atherosclerosis	0.00116	0.00143	CcSEcCtD
Entacapone—Syncope—Niacin—atherosclerosis	0.00116	0.00143	CcSEcCtD
Entacapone—Confusional state—Simvastatin—atherosclerosis	0.00116	0.00143	CcSEcCtD
Entacapone—Leukopenia—Niacin—atherosclerosis	0.00116	0.00143	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—APOA5—atherosclerosis	0.00116	0.00612	CbGpPWpGaD
Entacapone—Urticaria—Rosuvastatin—atherosclerosis	0.00115	0.00142	CcSEcCtD
Entacapone—Oedema—Simvastatin—atherosclerosis	0.00115	0.00142	CcSEcCtD
Entacapone—Malaise—Pravastatin—atherosclerosis	0.00115	0.00142	CcSEcCtD
Entacapone—Abdominal pain—Rosuvastatin—atherosclerosis	0.00115	0.00141	CcSEcCtD
Entacapone—Vertigo—Pravastatin—atherosclerosis	0.00114	0.00141	CcSEcCtD
Entacapone—Palpitations—Niacin—atherosclerosis	0.00114	0.00141	CcSEcCtD
Entacapone—Leukopenia—Pravastatin—atherosclerosis	0.00114	0.00141	CcSEcCtD
Entacapone—Loss of consciousness—Niacin—atherosclerosis	0.00114	0.0014	CcSEcCtD
Entacapone—Cough—Niacin—atherosclerosis	0.00113	0.00139	CcSEcCtD
Entacapone—Thrombocytopenia—Simvastatin—atherosclerosis	0.00113	0.00139	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00112	0.00138	CcSEcCtD
Entacapone—Insomnia—Lovastatin—atherosclerosis	0.00111	0.00137	CcSEcCtD
Entacapone—Cough—Pravastatin—atherosclerosis	0.00111	0.00137	CcSEcCtD
Entacapone—Paraesthesia—Lovastatin—atherosclerosis	0.0011	0.00136	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—ABCA1—atherosclerosis	0.0011	0.00585	CbGpPWpGaD
Entacapone—Myalgia—Niacin—atherosclerosis	0.0011	0.00136	CcSEcCtD
Entacapone—Hypertension—Pravastatin—atherosclerosis	0.0011	0.00136	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.0011	0.00135	CcSEcCtD
Entacapone—Anorexia—Simvastatin—atherosclerosis	0.0011	0.00135	CcSEcCtD
Entacapone—Dyspnoea—Lovastatin—atherosclerosis	0.0011	0.00135	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00109	0.00135	CcSEcCtD
Entacapone—Insomnia—Ezetimibe—atherosclerosis	0.00109	0.00134	CcSEcCtD
Entacapone—Chest pain—Pravastatin—atherosclerosis	0.00108	0.00134	CcSEcCtD
Entacapone—Myalgia—Pravastatin—atherosclerosis	0.00108	0.00134	CcSEcCtD
Entacapone—Paraesthesia—Ezetimibe—atherosclerosis	0.00108	0.00134	CcSEcCtD
Entacapone—Dyspepsia—Lovastatin—atherosclerosis	0.00108	0.00133	CcSEcCtD
Entacapone—Anxiety—Pravastatin—atherosclerosis	0.00108	0.00133	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—atherosclerosis	0.00108	0.00573	CbGpPWpGaD
Entacapone—Dry mouth—Niacin—atherosclerosis	0.00108	0.00133	CcSEcCtD
Entacapone—Dyspnoea—Ezetimibe—atherosclerosis	0.00108	0.00133	CcSEcCtD
Entacapone—Discomfort—Pravastatin—atherosclerosis	0.00107	0.00132	CcSEcCtD
Entacapone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.00107	0.00132	CcSEcCtD
Entacapone—Decreased appetite—Lovastatin—atherosclerosis	0.00107	0.00132	CcSEcCtD
Entacapone—Dyspepsia—Ezetimibe—atherosclerosis	0.00106	0.00131	CcSEcCtD
Entacapone—Fatigue—Lovastatin—atherosclerosis	0.00106	0.00131	CcSEcCtD
Entacapone—Oedema—Niacin—atherosclerosis	0.00106	0.0013	CcSEcCtD
Entacapone—UGT1A9—Phase II conjugation—GSTM1—atherosclerosis	0.00105	0.00559	CbGpPWpGaD
Entacapone—Pain—Lovastatin—atherosclerosis	0.00105	0.0013	CcSEcCtD
Entacapone—Constipation—Lovastatin—atherosclerosis	0.00105	0.0013	CcSEcCtD
Entacapone—Confusional state—Pravastatin—atherosclerosis	0.00105	0.00129	CcSEcCtD
Entacapone—Decreased appetite—Ezetimibe—atherosclerosis	0.00105	0.00129	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00105	0.00129	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—atherosclerosis	0.00104	0.00552	CbGpPWpGaD
Entacapone—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.00104	0.00128	CcSEcCtD
Entacapone—Asthenia—Rosuvastatin—atherosclerosis	0.00104	0.00128	CcSEcCtD
Entacapone—Insomnia—Simvastatin—atherosclerosis	0.00104	0.00128	CcSEcCtD
Entacapone—Oedema—Pravastatin—atherosclerosis	0.00104	0.00128	CcSEcCtD
Entacapone—Fatigue—Ezetimibe—atherosclerosis	0.00104	0.00128	CcSEcCtD
Entacapone—Shock—Niacin—atherosclerosis	0.00104	0.00128	CcSEcCtD
Entacapone—Paraesthesia—Simvastatin—atherosclerosis	0.00103	0.00127	CcSEcCtD
Entacapone—Pain—Ezetimibe—atherosclerosis	0.00103	0.00127	CcSEcCtD
Entacapone—Constipation—Ezetimibe—atherosclerosis	0.00103	0.00127	CcSEcCtD
Entacapone—COMT—Biological oxidations—GSTM1—atherosclerosis	0.00103	0.00546	CbGpPWpGaD
Entacapone—Pruritus—Rosuvastatin—atherosclerosis	0.00103	0.00127	CcSEcCtD
Entacapone—Skin disorder—Niacin—atherosclerosis	0.00103	0.00126	CcSEcCtD
Entacapone—Dyspnoea—Simvastatin—atherosclerosis	0.00103	0.00126	CcSEcCtD
Entacapone—Hyperhidrosis—Niacin—atherosclerosis	0.00102	0.00126	CcSEcCtD
Entacapone—Thrombocytopenia—Pravastatin—atherosclerosis	0.00102	0.00126	CcSEcCtD
Entacapone—COMT—Metapathway biotransformation—GSTM1—atherosclerosis	0.00102	0.00538	CbGpPWpGaD
Entacapone—Feeling abnormal—Lovastatin—atherosclerosis	0.00101	0.00125	CcSEcCtD
Entacapone—Dyspepsia—Simvastatin—atherosclerosis	0.00101	0.00125	CcSEcCtD
Entacapone—Anorexia—Niacin—atherosclerosis	0.00101	0.00124	CcSEcCtD
Entacapone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00101	0.00124	CcSEcCtD
Entacapone—Hyperhidrosis—Pravastatin—atherosclerosis	0.00101	0.00124	CcSEcCtD
Entacapone—Decreased appetite—Simvastatin—atherosclerosis	0.001	0.00123	CcSEcCtD
Entacapone—Feeling abnormal—Ezetimibe—atherosclerosis	0.000994	0.00123	CcSEcCtD
Entacapone—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000993	0.00122	CcSEcCtD
Entacapone—Diarrhoea—Rosuvastatin—atherosclerosis	0.000993	0.00122	CcSEcCtD
Entacapone—Fatigue—Simvastatin—atherosclerosis	0.000992	0.00122	CcSEcCtD
Entacapone—Anorexia—Pravastatin—atherosclerosis	0.000991	0.00122	CcSEcCtD
Entacapone—Hypotension—Niacin—atherosclerosis	0.000987	0.00122	CcSEcCtD
Entacapone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000986	0.00122	CcSEcCtD
Entacapone—Constipation—Simvastatin—atherosclerosis	0.000984	0.00121	CcSEcCtD
Entacapone—Pain—Simvastatin—atherosclerosis	0.000984	0.00121	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000982	0.00521	CbGpPWpGaD
Entacapone—Urticaria—Lovastatin—atherosclerosis	0.000977	0.0012	CcSEcCtD
Entacapone—Body temperature increased—Lovastatin—atherosclerosis	0.000972	0.0012	CcSEcCtD
Entacapone—Abdominal pain—Lovastatin—atherosclerosis	0.000972	0.0012	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000962	0.00119	CcSEcCtD
Entacapone—Dizziness—Rosuvastatin—atherosclerosis	0.00096	0.00118	CcSEcCtD
Entacapone—Urticaria—Ezetimibe—atherosclerosis	0.000958	0.00118	CcSEcCtD
Entacapone—Insomnia—Niacin—atherosclerosis	0.000955	0.00118	CcSEcCtD
Entacapone—Abdominal pain—Ezetimibe—atherosclerosis	0.000954	0.00118	CcSEcCtD
Entacapone—Body temperature increased—Ezetimibe—atherosclerosis	0.000954	0.00118	CcSEcCtD
Entacapone—Paraesthesia—Niacin—atherosclerosis	0.000948	0.00117	CcSEcCtD
Entacapone—Feeling abnormal—Simvastatin—atherosclerosis	0.000948	0.00117	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000947	0.00117	CcSEcCtD
Entacapone—Dyspnoea—Niacin—atherosclerosis	0.000942	0.00116	CcSEcCtD
Entacapone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000941	0.00116	CcSEcCtD
Entacapone—Insomnia—Pravastatin—atherosclerosis	0.000941	0.00116	CcSEcCtD
Entacapone—Somnolence—Niacin—atherosclerosis	0.000939	0.00116	CcSEcCtD
Entacapone—Paraesthesia—Pravastatin—atherosclerosis	0.000934	0.00115	CcSEcCtD
Entacapone—Dyspepsia—Niacin—atherosclerosis	0.00093	0.00115	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL1B—atherosclerosis	0.00093	0.00493	CbGpPWpGaD
Entacapone—Dyspnoea—Pravastatin—atherosclerosis	0.000927	0.00114	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000924	0.0049	CbGpPWpGaD
Entacapone—Decreased appetite—Niacin—atherosclerosis	0.000918	0.00113	CcSEcCtD
Entacapone—Dyspepsia—Pravastatin—atherosclerosis	0.000915	0.00113	CcSEcCtD
Entacapone—Rash—Rosuvastatin—atherosclerosis	0.000915	0.00113	CcSEcCtD
Entacapone—Dermatitis—Rosuvastatin—atherosclerosis	0.000914	0.00113	CcSEcCtD
Entacapone—Urticaria—Simvastatin—atherosclerosis	0.000914	0.00113	CcSEcCtD
Entacapone—Gastrointestinal disorder—Niacin—atherosclerosis	0.000912	0.00112	CcSEcCtD
Entacapone—Abdominal pain—Simvastatin—atherosclerosis	0.000909	0.00112	CcSEcCtD
Entacapone—Body temperature increased—Simvastatin—atherosclerosis	0.000909	0.00112	CcSEcCtD
Entacapone—Headache—Rosuvastatin—atherosclerosis	0.000909	0.00112	CcSEcCtD
Entacapone—Hypersensitivity—Lovastatin—atherosclerosis	0.000906	0.00112	CcSEcCtD
Entacapone—Decreased appetite—Pravastatin—atherosclerosis	0.000904	0.00111	CcSEcCtD
Entacapone—Pain—Niacin—atherosclerosis	0.000903	0.00111	CcSEcCtD
Entacapone—Fatigue—Pravastatin—atherosclerosis	0.000897	0.00111	CcSEcCtD
Entacapone—Constipation—Pravastatin—atherosclerosis	0.000889	0.0011	CcSEcCtD
Entacapone—Pain—Pravastatin—atherosclerosis	0.000889	0.0011	CcSEcCtD
Entacapone—Hypersensitivity—Ezetimibe—atherosclerosis	0.000889	0.0011	CcSEcCtD
Entacapone—Asthenia—Lovastatin—atherosclerosis	0.000882	0.00109	CcSEcCtD
Entacapone—COMT—Transmission across Chemical Synapses—PRKCG—atherosclerosis	0.000871	0.00462	CbGpPWpGaD
Entacapone—Pruritus—Lovastatin—atherosclerosis	0.00087	0.00107	CcSEcCtD
Entacapone—Asthenia—Ezetimibe—atherosclerosis	0.000865	0.00107	CcSEcCtD
Entacapone—Gastrointestinal pain—Niacin—atherosclerosis	0.000864	0.00106	CcSEcCtD
Entacapone—Nausea—Rosuvastatin—atherosclerosis	0.000862	0.00106	CcSEcCtD
Entacapone—Feeling abnormal—Pravastatin—atherosclerosis	0.000857	0.00106	CcSEcCtD
Entacapone—Pruritus—Ezetimibe—atherosclerosis	0.000853	0.00105	CcSEcCtD
Entacapone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00085	0.00105	CcSEcCtD
Entacapone—Hypersensitivity—Simvastatin—atherosclerosis	0.000847	0.00104	CcSEcCtD
Entacapone—Diarrhoea—Lovastatin—atherosclerosis	0.000841	0.00104	CcSEcCtD
Entacapone—Urticaria—Niacin—atherosclerosis	0.000839	0.00103	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—HMGCR—atherosclerosis	0.000835	0.00443	CbGpPWpGaD
Entacapone—Body temperature increased—Niacin—atherosclerosis	0.000835	0.00103	CcSEcCtD
Entacapone—Abdominal pain—Niacin—atherosclerosis	0.000835	0.00103	CcSEcCtD
Entacapone—Urticaria—Pravastatin—atherosclerosis	0.000826	0.00102	CcSEcCtD
Entacapone—Asthenia—Simvastatin—atherosclerosis	0.000825	0.00102	CcSEcCtD
Entacapone—Diarrhoea—Ezetimibe—atherosclerosis	0.000825	0.00102	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—CD36—atherosclerosis	0.000823	0.00436	CbGpPWpGaD
Entacapone—Body temperature increased—Pravastatin—atherosclerosis	0.000822	0.00101	CcSEcCtD
Entacapone—Abdominal pain—Pravastatin—atherosclerosis	0.000822	0.00101	CcSEcCtD
Entacapone—Pruritus—Simvastatin—atherosclerosis	0.000814	0.001	CcSEcCtD
Entacapone—Dizziness—Lovastatin—atherosclerosis	0.000813	0.001	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—atherosclerosis	0.000805	0.00427	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000801	0.00424	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000801	0.00424	CbGpPWpGaD
Entacapone—Dizziness—Ezetimibe—atherosclerosis	0.000798	0.000983	CcSEcCtD
Entacapone—Diarrhoea—Simvastatin—atherosclerosis	0.000787	0.00097	CcSEcCtD
Entacapone—Vomiting—Lovastatin—atherosclerosis	0.000782	0.000964	CcSEcCtD
Entacapone—Hypersensitivity—Niacin—atherosclerosis	0.000778	0.000959	CcSEcCtD
Entacapone—Rash—Lovastatin—atherosclerosis	0.000775	0.000956	CcSEcCtD
Entacapone—Dermatitis—Lovastatin—atherosclerosis	0.000775	0.000955	CcSEcCtD
Entacapone—Headache—Lovastatin—atherosclerosis	0.00077	0.00095	CcSEcCtD
Entacapone—Vomiting—Ezetimibe—atherosclerosis	0.000767	0.000945	CcSEcCtD
Entacapone—Hypersensitivity—Pravastatin—atherosclerosis	0.000766	0.000944	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—PPARA—atherosclerosis	0.000765	0.00405	CbGpPWpGaD
Entacapone—Dizziness—Simvastatin—atherosclerosis	0.000761	0.000938	CcSEcCtD
Entacapone—Rash—Ezetimibe—atherosclerosis	0.000761	0.000937	CcSEcCtD
Entacapone—Dermatitis—Ezetimibe—atherosclerosis	0.00076	0.000937	CcSEcCtD
Entacapone—Asthenia—Niacin—atherosclerosis	0.000758	0.000934	CcSEcCtD
Entacapone—Headache—Ezetimibe—atherosclerosis	0.000756	0.000931	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—HMOX1—atherosclerosis	0.000755	0.004	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atherosclerosis	0.000749	0.00397	CbGpPWpGaD
Entacapone—Pruritus—Niacin—atherosclerosis	0.000747	0.000921	CcSEcCtD
Entacapone—Asthenia—Pravastatin—atherosclerosis	0.000746	0.00092	CcSEcCtD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—atherosclerosis	0.000744	0.00394	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—AGT—atherosclerosis	0.000741	0.00393	CbGpPWpGaD
Entacapone—Pruritus—Pravastatin—atherosclerosis	0.000736	0.000907	CcSEcCtD
Entacapone—Vomiting—Simvastatin—atherosclerosis	0.000731	0.000901	CcSEcCtD
Entacapone—Nausea—Lovastatin—atherosclerosis	0.00073	0.0009	CcSEcCtD
Entacapone—COMT—Metabolism—LDLRAP1—atherosclerosis	0.00073	0.00387	CbGpPWpGaD
Entacapone—Rash—Simvastatin—atherosclerosis	0.000725	0.000894	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—atherosclerosis	0.000725	0.00384	CbGpPWpGaD
Entacapone—Dermatitis—Simvastatin—atherosclerosis	0.000725	0.000893	CcSEcCtD
Entacapone—Diarrhoea—Niacin—atherosclerosis	0.000723	0.000891	CcSEcCtD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—atherosclerosis	0.000722	0.00383	CbGpPWpGaD
Entacapone—Headache—Simvastatin—atherosclerosis	0.000721	0.000888	CcSEcCtD
Entacapone—UGT1A9—PPARA activates gene expression—APOA1—atherosclerosis	0.000718	0.0038	CbGpPWpGaD
Entacapone—Nausea—Ezetimibe—atherosclerosis	0.000716	0.000883	CcSEcCtD
Entacapone—Diarrhoea—Pravastatin—atherosclerosis	0.000712	0.000877	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—GSTM1—atherosclerosis	0.000704	0.00373	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—atherosclerosis	0.000702	0.00372	CbGpPWpGaD
Entacapone—Dizziness—Niacin—atherosclerosis	0.000698	0.000861	CcSEcCtD
Entacapone—Dizziness—Pravastatin—atherosclerosis	0.000688	0.000848	CcSEcCtD
Entacapone—COMT—Metabolism—PLTP—atherosclerosis	0.000687	0.00364	CbGpPWpGaD
Entacapone—Nausea—Simvastatin—atherosclerosis	0.000683	0.000842	CcSEcCtD
Entacapone—UGT1A9—NRF2 pathway—AGER—atherosclerosis	0.000678	0.0036	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—atherosclerosis	0.000675	0.00358	CbGpPWpGaD
Entacapone—Vomiting—Niacin—atherosclerosis	0.000672	0.000828	CcSEcCtD
Entacapone—COMT—Neuronal System—PRKCG—atherosclerosis	0.000668	0.00354	CbGpPWpGaD
Entacapone—Rash—Niacin—atherosclerosis	0.000666	0.000821	CcSEcCtD
Entacapone—Dermatitis—Niacin—atherosclerosis	0.000665	0.00082	CcSEcCtD
Entacapone—Headache—Niacin—atherosclerosis	0.000662	0.000816	CcSEcCtD
Entacapone—Vomiting—Pravastatin—atherosclerosis	0.000661	0.000815	CcSEcCtD
Entacapone—Rash—Pravastatin—atherosclerosis	0.000656	0.000808	CcSEcCtD
Entacapone—Dermatitis—Pravastatin—atherosclerosis	0.000655	0.000807	CcSEcCtD
Entacapone—Headache—Pravastatin—atherosclerosis	0.000652	0.000803	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000633	0.00336	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—PPARG—atherosclerosis	0.000632	0.00335	CbGpPWpGaD
Entacapone—Nausea—Niacin—atherosclerosis	0.000627	0.000773	CcSEcCtD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—atherosclerosis	0.000619	0.00328	CbGpPWpGaD
Entacapone—Nausea—Pravastatin—atherosclerosis	0.000618	0.000761	CcSEcCtD
Entacapone—UGT1A9—Biological oxidations—GSTM1—atherosclerosis	0.000617	0.00327	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—atherosclerosis	0.000609	0.00323	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—PDGFB—atherosclerosis	0.000605	0.00321	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCG8—atherosclerosis	0.000595	0.00316	CbGpPWpGaD
Entacapone—COMT—Metabolism—LTA4H—atherosclerosis	0.000595	0.00316	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000595	0.00315	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000595	0.00315	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000584	0.0031	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000574	0.00304	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—atherosclerosis	0.000555	0.00294	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000531	0.00281	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atherosclerosis	0.000516	0.00273	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000503	0.00267	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000503	0.00267	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000503	0.00267	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000503	0.00267	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—atherosclerosis	0.0005	0.00265	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000497	0.00263	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—atherosclerosis	0.000484	0.00256	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.00048	0.00254	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCG1—atherosclerosis	0.000471	0.00249	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00046	0.00244	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000443	0.00235	CbGpPWpGaD
Entacapone—COMT—Metabolism—FABP4—atherosclerosis	0.000442	0.00235	CbGpPWpGaD
Entacapone—COMT—Metabolism—LCAT—atherosclerosis	0.000442	0.00235	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LDLRAP1—atherosclerosis	0.000438	0.00232	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOA4—atherosclerosis	0.000434	0.0023	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000428	0.00227	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP7A1—atherosclerosis	0.000427	0.00226	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—atherosclerosis	0.000426	0.00226	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLTP—atherosclerosis	0.000411	0.00218	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP27A1—atherosclerosis	0.000394	0.00209	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000381	0.00202	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000379	0.00201	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000376	0.002	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOA2—atherosclerosis	0.000374	0.00198	CbGpPWpGaD
Entacapone—COMT—Metabolism—PLA2G2A—atherosclerosis	0.000374	0.00198	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALOX15—atherosclerosis	0.000374	0.00198	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALOX5AP—atherosclerosis	0.000374	0.00198	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCG5—atherosclerosis	0.000369	0.00196	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000368	0.00195	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LTA4H—atherosclerosis	0.000357	0.00189	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCG8—atherosclerosis	0.000357	0.00189	CbGpPWpGaD
Entacapone—COMT—Metabolism—LPA—atherosclerosis	0.000357	0.00189	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000352	0.00187	CbGpPWpGaD
Entacapone—COMT—Metabolism—BGN—atherosclerosis	0.000345	0.00183	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOA5—atherosclerosis	0.000342	0.00181	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000333	0.00176	CbGpPWpGaD
Entacapone—COMT—Metabolism—PLA2G1B—atherosclerosis	0.000329	0.00174	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALOX5—atherosclerosis	0.000318	0.00168	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000296	0.00157	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFB1—atherosclerosis	0.000287	0.00152	CbGpPWpGaD
Entacapone—COMT—Metabolism—NAMPT—atherosclerosis	0.000285	0.00151	CbGpPWpGaD
Entacapone—COMT—Metabolism—LIPC—atherosclerosis	0.000283	0.0015	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCG1—atherosclerosis	0.000282	0.00149	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOC3—atherosclerosis	0.000282	0.00149	CbGpPWpGaD
Entacapone—COMT—Metabolism—LDLR—atherosclerosis	0.00028	0.00148	CbGpPWpGaD
Entacapone—COMT—Metabolism—CETP—atherosclerosis	0.000273	0.00145	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—FABP4—atherosclerosis	0.000265	0.0014	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LCAT—atherosclerosis	0.000265	0.0014	CbGpPWpGaD
Entacapone—COMT—Metabolism—SCARB1—atherosclerosis	0.000262	0.00139	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOA4—atherosclerosis	0.00026	0.00138	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP7A1—atherosclerosis	0.000256	0.00135	CbGpPWpGaD
Entacapone—COMT—Metabolism—HMGCR—atherosclerosis	0.000247	0.00131	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000244	0.00129	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP27A1—atherosclerosis	0.000236	0.00125	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000233	0.00123	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000227	0.0012	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALOX15—atherosclerosis	0.000224	0.00119	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALOX5AP—atherosclerosis	0.000224	0.00119	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOA2—atherosclerosis	0.000224	0.00119	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLA2G2A—atherosclerosis	0.000224	0.00119	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCG5—atherosclerosis	0.000221	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.000221	0.00117	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCA1—atherosclerosis	0.00022	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LPA—atherosclerosis	0.000214	0.00113	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BGN—atherosclerosis	0.000207	0.0011	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000205	0.00109	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOA5—atherosclerosis	0.000205	0.00109	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000199	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLA2G1B—atherosclerosis	0.000197	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000195	0.00103	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.000193	0.00102	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000193	0.00102	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALOX5—atherosclerosis	0.00019	0.00101	CbGpPWpGaD
Entacapone—COMT—Metabolism—HMOX1—atherosclerosis	0.000189	0.001	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOB—atherosclerosis	0.000181	0.00096	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTM1—atherosclerosis	0.000176	0.000934	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000176	0.000933	CbGpPWpGaD
Entacapone—COMT—Metabolism—LPL—atherosclerosis	0.000173	0.000916	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NAMPT—atherosclerosis	0.000171	0.000905	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.00017	0.0009	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LIPC—atherosclerosis	0.00017	0.0009	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOC3—atherosclerosis	0.000169	0.000894	CbGpPWpGaD
Entacapone—COMT—Metabolism—GPX1—atherosclerosis	0.000169	0.000894	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LDLR—atherosclerosis	0.000168	0.000889	CbGpPWpGaD
Entacapone—COMT—Metabolism—CD36—atherosclerosis	0.000164	0.000871	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CETP—atherosclerosis	0.000164	0.000868	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SCARB1—atherosclerosis	0.000157	0.000831	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTHFR—atherosclerosis	0.000156	0.000825	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARA—atherosclerosis	0.000153	0.000809	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000153	0.000809	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMGCR—atherosclerosis	0.000148	0.000785	CbGpPWpGaD
Entacapone—COMT—Metabolism—AGT—atherosclerosis	0.000148	0.000784	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOE—atherosclerosis	0.000145	0.000768	CbGpPWpGaD
Entacapone—COMT—Metabolism—CAV1—atherosclerosis	0.000144	0.000761	CbGpPWpGaD
Entacapone—COMT—Metabolism—APOA1—atherosclerosis	0.000143	0.000759	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000134	0.000708	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCA1—atherosclerosis	0.000132	0.0007	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CG—atherosclerosis	0.000131	0.000693	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARG—atherosclerosis	0.000126	0.000669	CbGpPWpGaD
Entacapone—COMT—Metabolism—INS—atherosclerosis	0.000124	0.000656	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALB—atherosclerosis	0.000114	0.000602	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMOX1—atherosclerosis	0.000113	0.0006	CbGpPWpGaD
Entacapone—COMT—Metabolism—NOS3—atherosclerosis	0.000109	0.000575	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOB—atherosclerosis	0.000108	0.000575	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—atherosclerosis	0.000106	0.000559	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LPL—atherosclerosis	0.000104	0.000549	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GPX1—atherosclerosis	0.000101	0.000536	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—atherosclerosis	9.93e-05	0.000526	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CD36—atherosclerosis	9.84e-05	0.000522	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTHFR—atherosclerosis	9.33e-05	0.000494	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARA—atherosclerosis	9.15e-05	0.000485	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AGT—atherosclerosis	8.86e-05	0.00047	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOE—atherosclerosis	8.68e-05	0.00046	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAV1—atherosclerosis	8.6e-05	0.000456	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APOA1—atherosclerosis	8.58e-05	0.000455	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CG—atherosclerosis	7.84e-05	0.000415	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PPARG—atherosclerosis	7.56e-05	0.000401	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—INS—atherosclerosis	7.42e-05	0.000393	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—atherosclerosis	6.8e-05	0.00036	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NOS3—atherosclerosis	6.51e-05	0.000345	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—atherosclerosis	5.95e-05	0.000315	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—atherosclerosis	4.99e-05	0.000265	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—atherosclerosis	2.99e-05	0.000158	CbGpPWpGaD
